Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety and Effectiveness of CRISPR-Cas9 Modified Stem Cells for Patients with Transfusion-Dependent Beta-Thalassemia Using Exagamglogene Autotemcel

    Not recruiting

    1 1 1 1
    Germany
  • Study on Dexamethasone for Patients with Herpes Simplex Virus Encephalitis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Atorvastatin for Patients with Early Breast Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on the Effectiveness and Safety of Vosoritide for Children with Hypochondroplasia

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain
  • A study comparing TAP block versus QL block with ropivacaine for pain management after laparoscopic colon resection in patients with colon cancer or diverticulosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland
  • Study of Chemotherapy with Osimertinib in Non-Small Cell Lung Cancer Patients Who Have Progressed After Initial Osimertinib Treatment

    Not recruiting

    1 1 1
    Investigated diseases:
    Germany Italy Spain
  • Study on the Safety and Effectiveness of Trifluridine/Tipiracil, Capecitabine, and Bevacizumab for Patients with Metastatic Colorectal Cancer Unfit for Intensive Chemotherapy

    Not recruiting

    1 1 1
    Italy
  • Study of Pembrolizumab with Hyaluronidase for Patients with Relapsed or Refractory Hodgkin Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    1 1
    Investigated drugs:
    Germany Poland Spain
  • Study of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Treating Multiple Myeloma Patients with Extramedullary Disease

    Not recruiting

    1 1 1
    Greece Italy
  • Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Czechia Denmark France +12